LITTLE GREEN PHARMA LTD
ASX:LGPPharmaceuticals, Biotechnology & Life SciencesRunway under 2 quarters; share count grew 175% in 24 months; options/rights overhang 26% of shares
LITTLE GREEN PHARMA LTD's ordinary share count grew 174.6% between April 2024 and July 2026, to 828M shares. There were no capital raises in the 24-month window. Options and rights on issue could convert into 220M new shares, equal to 26.5% of the current share count, with 0% in the money at the current share price and the nearest expiry in July 2027. At the March 2026 quarter the company reported A$2.1M in available cash, representing 0.0 quarters of funding at its recent spending rate. No proposed securities issues (Appendix 3B) are pending.
Shares on issue — last 2 years
Cash runway
Issuance timeline
Latest 5 filings (Appendix 2A quoted issues, 3G unquoted, 3H cancellations)
| Date | Form | Security | Total on issue after | Source |
|---|---|---|---|---|
| 27 July 2026 | 2A · quoted issue | LGP : ORDINARY FULLY PAID | 828.0M | Appendix 2A |
| 14 July 2026 | 2A · quoted issue | LGP : ORDINARY FULLY PAID | 824.0M | Appendix 2A |
| 31 May 2026 | 2A · quoted issue | LGP : ORDINARY FULLY PAID | 307.3M | Appendix 2A |
| 31 May 2026 | 2A · quoted issue | LGP : ORDINARY FULLY PAID | 308.3M | Appendix 2A |
| 31 May 2026 | 3G · unquoted | LGP : ORDINARY FULLY PAID | 307.1M | Appendix 3G |
Capital raises
Pending proposed issues
Options & convertible securities
Director dealings
Ownership
Latest announcements
Headlines link to the source PDFs on the ASX announcements platform. Data as of 28 July 2026.